ID   ARF_RAT                 Reviewed;         160 AA.
AC   Q8QZZ9;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   02-OCT-2024, entry version 112.
DE   RecName: Full=Tumor suppressor ARF {ECO:0000305};
DE   AltName: Full=Alternative reading frame;
DE            Short=ARF;
DE   AltName: Full=Cyclin-dependent kinase inhibitor 2A;
DE   AltName: Full=p19ARF;
GN   Name=Cdkn2a {ECO:0000312|EMBL:AAL76336.1, ECO:0000312|RGD:2323};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAL76336.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=ACI/SegHsd {ECO:0000312|EMBL:AAL76336.1},
RC   Brown Norway/SsNHsd {ECO:0000312|EMBL:AAT92509.1}, and
RC   COP {ECO:0000312|EMBL:AAL76337.1};
RC   TISSUE=Lung {ECO:0000312|EMBL:AAL76336.1};
RA   Buckles L.K., Shull J.D.;
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-63, AND TISSUE SPECIFICITY.
RC   STRAIN=Fischer 344/N;
RX   PubMed=9032263; DOI=10.1128/mcb.17.3.1366;
RA   Swafford D.S., Middleton S.K., Palmisano W.A., Nikula K.J., Tesfaigzi J.,
RA   Baylin S.B., Herman J.G., Belinsky S.A.;
RT   "Frequent aberrant methylation of p16INK4a in primary rat lung tumors.";
RL   Mol. Cell. Biol. 17:1366-1374(1997).
CC   -!- FUNCTION: Capable of inducing cell cycle arrest in G1 and G2 phases.
CC       Acts as a tumor suppressor. Binds to MDM2 and blocks its
CC       nucleocytoplasmic shuttling by sequestering it in the nucleolus. This
CC       inhibits the oncogenic action of MDM2 by blocking MDM2-induced
CC       degradation of p53 and enhancing p53-dependent transactivation and
CC       apoptosis. Also induces G2 arrest and apoptosis in a p53-independent
CC       manner by preventing the activation of cyclin B1/CDC2 complexes. Binds
CC       to BCL6 and down-regulates BCL6-induced transcriptional repression.
CC       Binds to E2F1 and MYC and blocks their transcriptional activator
CC       activity but has no effect on MYC transcriptional repression. Binds to
CC       TOP1/TOPOI and stimulates its activity. This complex binds to rRNA gene
CC       promoters and may play a role in rRNA transcription and/or maturation.
CC       Interacts with NPM1/B23 and promotes its polyubiquitination and
CC       degradation, thus inhibiting rRNA processing. Plays a role in
CC       inhibiting ribosome biogenesis, perhaps by binding to the nucleolar
CC       localization sequence of transcription termination factor TTF1, and
CC       thereby preventing nucleolar localization of TTF1 (By similarity).
CC       Interacts with COMMD1 and promotes its 'Lys63'-linked
CC       polyubiquitination. Interacts with UBE2I/UBC9 and enhances sumoylation
CC       of a number of its binding partners including MDM2 and E2F1. Binds to
CC       HUWE1 and represses its ubiquitin ligase activity. May play a role in
CC       controlling cell proliferation and apoptosis during mammary gland
CC       development (By similarity). {ECO:0000250|UniProtKB:Q64364,
CC       ECO:0000250|UniProtKB:Q8N726}.
CC   -!- SUBUNIT: Does not interact with cyclins, CDK1, CDK2, CDK4, CDK5 or
CC       CDK6. Binds to BCL6, E2F1, HUWE1, MDM2, MYC, NPM1/B23, TOP1/TOPOI and
CC       UBE2I/UBC9. Interacts with TBRG1 and COMMD1. Interacts with CDKN2AIP
CC       and E4F1. Interacts with CDK5RAP3 and MDM2; form a ternary complex
CC       involved in regulation of p53/TP53. Interacts with NOP53; the
CC       interaction is direct and promotes ARF nucleoplasmic relocalization and
CC       ubiquitin-mediated proteasomal degradation (By similarity). Interacts
CC       with TTF1 (via the N-terminal region (NRD) and a C-terminal region);
CC       the interaction is direct and inhibits the nucleolar localization of
CC       TTF1 (By similarity). {ECO:0000250|UniProtKB:Q64364,
CC       ECO:0000250|UniProtKB:Q8N726}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:Q8N726}. Nucleus, nucleoplasm
CC       {ECO:0000250|UniProtKB:Q8N726}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Isoform 1 and isoform tumor suppressor ARF arise due to the
CC         use of two alternative first exons joined to a common exon 2 at the
CC         same acceptor site but in different reading frames, resulting in two
CC         completely different isoforms. {ECO:0000250|UniProtKB:Q64363};
CC       Name=tumor suppressor ARF {ECO:0000250|UniProtKB:Q64363};
CC       Synonyms=p19ARF;
CC         IsoId=Q8QZZ9-1; Sequence=Displayed;
CC       Name=1 {ECO:0000250|UniProtKB:Q8N726}; Synonyms=p16INK4a
CC       {ECO:0000250|UniProtKB:Q8N726};
CC         IsoId=Q9R0Z3-1; Sequence=External;
CC   -!- TISSUE SPECIFICITY: Widely expressed with very low levels in kidney and
CC       colon. {ECO:0000269|PubMed:9032263}.
CC   -!- PTM: Ubiquitinated in normal cells by TRIP12 via the ubiquitin fusion
CC       degradation (UFD) pathway, a process that mediates ubiquitination at
CC       the N-terminus, regardless of the absence of lysine residues.
CC       Ubiquitination leads to its proteasomal degradation. In cancer cells,
CC       however, TRIP12 is located in a different cell compartment, preventing
CC       ubiquitination and degradation. {ECO:0000250|UniProtKB:Q8N726}.
CC   -!- CAUTION: The proteins described here are encoded by the gene CDKN2A,
CC       but are completely unrelated in terms of sequence and function to
CC       cyclin-dependent kinase inhibitor 2A (AC Q9R0Z3) which is encoded by
CC       the same gene. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF474974; AAL76336.1; -; mRNA.
DR   EMBL; AF474975; AAL76337.1; -; mRNA.
DR   EMBL; AY679727; AAT92509.1; -; mRNA.
DR   EMBL; L81168; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; Q8QZZ9; -.
DR   STRING; 10116.ENSRNOP00000072063; -.
DR   iPTMnet; Q8QZZ9; -.
DR   PhosphoSitePlus; Q8QZZ9; -.
DR   UCSC; RGD:2323; rat. [Q8QZZ9-1]
DR   AGR; RGD:2323; -.
DR   RGD; 2323; Cdkn2a.
DR   InParanoid; Q8QZZ9; -.
DR   OrthoDB; 2321802at2759; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0001652; C:granular component; ISO:RGD.
DR   GO; GO:0005730; C:nucleolus; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0035985; C:senescence-associated heterochromatin focus; ISO:RGD.
DR   GO; GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; ISO:RGD.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0097371; F:MDM2/MDM4 family protein binding; ISO:RGD.
DR   GO; GO:0051059; F:NF-kappaB binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0019789; F:SUMO transferase activity; ISO:RGD.
DR   GO; GO:1990948; F:ubiquitin ligase inhibitor activity; ISO:RGD.
DR   GO; GO:0055105; F:ubiquitin-protein transferase inhibitor activity; ISO:RGD.
DR   GO; GO:1990000; P:amyloid fibril formation; ISO:RGD.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; ISO:RGD.
DR   GO; GO:0060057; P:apoptotic process involved in mammary gland involution; ISO:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; ISO:RGD.
DR   GO; GO:0090398; P:cellular senescence; ISO:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0008544; P:epidermis development; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0030216; P:keratinocyte differentiation; ISO:RGD.
DR   GO; GO:0043616; P:keratinocyte proliferation; ISO:RGD.
DR   GO; GO:0033598; P:mammary gland epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; ISO:RGD.
DR   GO; GO:0045786; P:negative regulation of cell cycle; ISO:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:2000346; P:negative regulation of hepatocyte proliferation; IMP:RGD.
DR   GO; GO:0033088; P:negative regulation of immature T cell proliferation in thymus; ISO:RGD.
DR   GO; GO:0033600; P:negative regulation of mammary gland epithelial cell proliferation; ISO:RGD.
DR   GO; GO:1904750; P:negative regulation of protein localization to nucleolus; ISO:RGD.
DR   GO; GO:2000435; P:negative regulation of protein neddylation; ISO:RGD.
DR   GO; GO:1903051; P:negative regulation of proteolysis involved in protein catabolic process; ISO:RGD.
DR   GO; GO:0090071; P:negative regulation of ribosome biogenesis; ISO:RGD.
DR   GO; GO:2000059; P:negative regulation of ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0022008; P:neurogenesis; IEP:RGD.
DR   GO; GO:0090402; P:oncogene-induced cell senescence; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0060058; P:positive regulation of apoptotic process involved in mammary gland involution; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:2000111; P:positive regulation of macrophage apoptotic process; ISO:RGD.
DR   GO; GO:0033235; P:positive regulation of protein sumoylation; ISO:RGD.
DR   GO; GO:0034393; P:positive regulation of smooth muscle cell apoptotic process; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0031648; P:protein destabilization; ISO:RGD.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISO:RGD.
DR   GO; GO:1902510; P:regulation of apoptotic DNA fragmentation; ISO:RGD.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0046822; P:regulation of nucleocytoplasmic transport; ISO:RGD.
DR   GO; GO:0031647; P:regulation of protein stability; ISO:RGD.
DR   GO; GO:0090399; P:replicative senescence; ISO:RGD.
DR   GO; GO:0061771; P:response to caloric restriction; IEP:RGD.
DR   GO; GO:0070542; P:response to fatty acid; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IDA:RGD.
DR   GO; GO:0009651; P:response to salt stress; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0006364; P:rRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0009303; P:rRNA transcription; ISO:RGD.
DR   GO; GO:0048103; P:somatic stem cell division; ISO:RGD.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISO:RGD.
DR   Gene3D; 6.10.250.60; -; 1.
DR   InterPro; IPR010868; Tumor_suppres_ARF.
DR   Pfam; PF07392; P19Arf_N; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Apoptosis; Cell cycle; DNA-binding; Nucleus;
KW   Reference proteome; rRNA processing; Transcription;
KW   Transcription regulation; Tumor suppressor; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN           1..160
FT                   /note="Tumor suppressor ARF"
FT                   /id="PRO_0000144183"
FT   REGION          1..63
FT                   /note="Interaction with CDK5RAP3 and MDM2"
FT                   /evidence="ECO:0000250|UniProtKB:Q8N726"
FT   REGION          49..74
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          90..116
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   160 AA;  17307 MW;  5A211F8315A66306 CRC64;
     MGRRFVVTVR IRRTGRSPQV RVFLVQFLGS SRPRSANGTR GFVALVLRPE RIARRGPQPH
     PGPGDDDGQR QSGSSPALLW CRFELRGPHH PLPTGARRSA GGLPRHSGST APGRGAAGCA
     RCLGSPAARP GPRAGTSRRR AVFAVSTLLR WERFPGHRQA
//
